GenSight Biologics announced the appointment of Elsy Boglioli to its Board of Directors, replacing Bpifrance Participations. Mrs. Boglioli is joining as an independent Director. Elsy is the founder and Chief Executive Officer of Bio-Up, a healthcare advisory firm supporting companies in strong scale up or transformation phases, mainly in the field of cell and gene therapy. She has far-reaching expertise and a broad network within the pharma and medtech industries. Before she created Bio-Up, Elsy was Executive Vice President, Chief Operating Officer at Cellectis, a French biotechnology company focused on gene editing and its applications in oncology.